Pyrroloquinoline-quinone suppresses liver fibrogenesis in mice

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Jia, Dongwei ^a   Duan, Fangfang ^a   Peng, Peike ^a   Sun, Linlin ^a   Ruan, Yuanyuan ^a   Gu, Jianxin ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PYRROLOQUINOLINEQUINONE; RECEPTOR FOR ACTIVATED C KINASE 1; SILYMARIN; ANTIOXIDANT; CYTOKINE; GNB2-RS1 PROTEIN, MOUSE; NEUROPEPTIDE; THIOACETAMIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIFIBROTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BINDING AFFINITY; CELL DEATH; CELL INFILTRATION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; FEMALE; IN VITRO STUDY; IN VIVO STUDY; LIVER FIBROSIS; MACROPHAGE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN BINDING; PROTEIN EXPRESSION; STELLATE CELL; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; CELL CULTURE; CELL MOTION; DISEASE MODEL; DRUG EFFECTS; HEPATIC STELLATE CELL; HUMAN; LIVER CELL; LIVER CIRRHOSIS; MALE; METABOLISM; PATHOLOGY;

MUS;

ANIMALS; ANTIOXIDANTS; CELL DEATH; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; DISEASE MODELS, ANIMAL; HEPATIC STELLATE CELLS; HEPATOCYTES; HUMANS; LIVER CIRRHOSIS; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; NEUROPEPTIDES; OXIDATIVE STRESS; PQQ COFACTOR; THIOACETAMIDE;

EID: 84926305528     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0121939     Document Type: Article

References (50)

1. Friedman S. Liver fibrosis? from bench to bedside. Journal of Hepatology. 2003; 38:38-53.
2. Sanchez-Valle V, Chavez-Tapia NC, Uribe M, Mendez-Sanchez N. Role of oxidative stress and molecular changes in liver fibrosis: a review. Curr Med Chem. 2012; 19(28):4850-60. PMID: 22709007
3. Bataller R, Brenner DA. Liver fibrosis. J Clin Invest. 2005; 115(2):209-18. PMID: 15690074
4. Zhang DY, Friedman SL. Fibrosis-dependent mechanisms of hepatocarcinogenesis. Hepatology. 2012; 56(2):769-75. doi: 10.1002/hep.25670 PMID: 22378017
5. Ellis EL, Mann DA. Clinical evidence for the regression of liver fibrosis. J Hepatol. 2012; 56(5):1171-80. doi: 10.1016/j.jhep.2011.09.024 PMID: 22245903
6. Bubici C, Papa S, Dean K, Franzoso G. Mutual cross-talk between reactive oxygen species and nuclear factor-kappa B: molecular basis and biological significance. Oncogene. 2006; 25(51):6731-48. PMID: 17072325
7. Mormone E, George J, Nieto N. Molecular pathogenesis of hepatic fibrosis and current therapeutic approaches. Chem Biol Interact. 2011; 193(3):225-31. doi: 10.1016/j.cbi.2011.07.001 PMID: 21803030
8. Parola M, Robino G. Oxidative stress-related molecules and liver fibrosis. J Hepatol. 2001; 35(2):297-306. PMID: 11580156
9. Poli G, Parola M. Oxidative damage and fibrogenesis. Free Radic Biol Med. 1997; 22(1-2):287-305.
10. Salisbury SA, Forrest HS, Cruse WB, Kennard O. A novel coenzyme from bacterial primary alcohol dehydrogenases. Nature. 1979; 280(5725):843-4. PMID: 471057
11. Westerling J, Frank J, Duine JA. The prosthetic group of methanol dehydrogenase from Hyphomicrobium X: electron spin resonance evidence for a quinone structure. Biochem Biophys Res Commun. 1979; 87(3):719-24. PMID: 222269
12. Kumazawa T, Sato K, Seno H, Ishii A, Suzuki O. Levels of pyrroloquinoline quinone in various foods. Biochem J. 1995; 307 (Pt 2):331-3.
13. Misra H, Rajpurohit YS, Khairnar NP. Pyrroloquinoline-quinone and its versatile roles in biological processes. J Biosci. 2012; 37(2):313-25. PMID: 22581337
14. Rucker R, Chowanadisai W, Nakano M. Potential physiological importance of pyrroloquinoline quinone. Altern Med Rev. 2009; 14(3):268-77. PMID: 19803551
15. Killgore J, Smidt C, Duich L, Romero-Chapman N, Tinker D, Reiser K, et al. Nutritional importance of pyrroloquinoline quinone. Science. 1989; 245(4920):850-2. PMID: 2549636
16. Steinberg FM, Gershwin ME, Rucker RB. Dietary pyrroloquinoline quinone: growth and immune response in BALB/c mice. J Nutr. 1994; 124(5):744-53. PMID: 8169668
17. Steinberg F, Stites TE, Anderson P, Storms D, Chan I, Eghbali S, et al. Pyrroloquinoline quinone improves growth and reproductive performance in mice fed chemically defined diets. Exp Biol Med (Maywood). 2003; 228(2):160-6. PMID: 12563022
18. Rucker R, Storms D, Sheets A, Tchaparian E, Fascetti A. Biochemistry: is pyrroloquinoline quinone a vitamin? Nature. 2005; 433(7025):E10-1; discussion E1-2. PMID: 15689995
19. Felton LM, Anthony C. Biochemistry: role of PQQ as a mammalian enzyme cofactor? Nature. 2005; 433(7025):E10; discussion E1-2. PMID: 15689995
20. Urakami T, Yoshida C, Akaike T, Maeda H, Nishigori H, Niki E. Synthesis of monoesters of pyrroloquinoline quinone and imidazopyrroloquinoline, and radical scavenging activities using electron spin resonance in vitro and pharmacological activity in vivo. J Nutr Sci Vitaminol (Tokyo). 1997; 43(1):19-33. PMID: 9151238
21. Misra HS, Khairnar NP, Barik A, Indira Priyadarsini K, Mohan H, Apte SK. Pyrroloquinoline-quinone: a reactive oxygen species scavenger in bacteria. FEBS Lett. 2004; 578(1-2):26-30.
22. Popov Y, Schuppan D. Targeting liver fibrosis: strategies for development and validation of antifibrotic therapies. Hepatology. 2009; 50(4):1294-306. doi: 10.1002/hep.23123 PMID: 19711424
23. Klemmer I, Yagi S, Gressner OA. Oral application of 1,7-dimethylxanthine (paraxanthine) attenuates the formation of experimental cholestatic liver fibrosis. Hepatol Res. 2011; 41(11):1094-109. doi: 10. 1111/j.1872-034X.2011.00856.x PMID: 22032678
24. Seki E, De Minicis S, Gwak GY, Kluwe J, Inokuchi S, Bursill CA, et al. CCR1 and CCR5 promote hepatic fibrosis in mice. J Clin Invest. 2009; 119(7):1858-70. PMID: 19603542
25. Song S, Zhang X, Wu H, Han Y, Zhang J, Ma E, et al. Molecular basis for antioxidant enzymes in mediating copper detoxification in the nematode Caenorhabditis elegans. PLoS One. 2014; 9(9):e107685. doi: 10.1371/journal.pone.0107685 PMID: 25243607
26. Chen W, Zhu HL, Shi Y, Zhao MM, Wang H, Zeng YQ. Comparative Analysis on Antioxidative Ability of Muscle between Laiwu Pig and Large White. Asian-Australas J Anim Sci. 2012; 25(8):1190-6. doi: 10. 5713/ajas.2012.12019 PMID: 25049680
27. Jia D, Duan F, Peng P, Sun L, Liu X, Wang L, et al. Up-regulation of RACK1 by TGF-beta1 promotes hepatic fibrosis in mice. PLoS One. 2013; 8(3):e60115. doi: 10.1371/journal.pone.0060115 PMID:23555900
28. Suzuki T, Shimizu T, Yu HP, Hsieh YC, Choudhry MA, Schwacha MG, et al. Tissue compartment-specific role of estrogen receptor subtypes in immune cell cytokine production following trauma-hemorrhage. J Appl Physiol (1985). 2007; 102(1):163-8. PMID: 17023568
29. Al-Attar AM. Attenuating effect of Ginkgo biloba leaves extract on liver fibrosis induced by thioacetamide in mice. J Biomed Biotechnol. 2012; 2012:761450. doi: 10.1155/2012/761450 PMID: 23091357
30. Canbay A, Friedman S, Gores GJ. Apoptosis: the nexus of liver injury and fibrosis. Hepatology. 2004;39(2):273-8. PMID: 14767974
31. Muriel P. Role of free radicals in liver diseases. Hepatol Int. 2009; 3(4):526-36. doi: 10.1007/s12072-009-9158-6 PMID: 19941170
32. Friedman SL. Mac the knife? Macrophages- the double-edged sword of hepatic fibrosis. J Clin Invest. 2005; 115(1):29-32. PMID: 15630440
33. Ramachandran P, Iredale JP. Macrophages: central regulators of hepatic fibrogenesis and fibrosis resolution. J Hepatol. 2012; 56(6):1417-9. doi: 10.1016/j.jhep.2011.10.026 PMID: 22314426
34. Tahashi Y, Matsuzaki K, Date M, Yoshida K, Furukawa F, Sugano Y, et al. Differential regulation of TGF-beta signal in hepatic stellate cells between acute and chronic rat liver injury. Hepatology. 2002;35(1):49-61. PMID: 11786959
35. Gressner AM, Weiskirchen R, Breitkopf K, Dooley S. Roles of TGF-beta in hepatic fibrosis. Front Biosci. 2002; 7:d793-807. PMID: 11897555
36. Marra F, Arrighi MC, Fazi M, Caligiuri A, Pinzani M, Romanelli RG, et al. Extracellular signal-regulated kinase activation differentially regulates platelet-derived growth factor's actions in hepatic stellate cells, and is induced by in vivo liver injury in the rat. Hepatology. 1999; 30(4):951-8. PMID: 10498647
37. Bonner JC. Regulation of PDGF and its receptors in fibrotic diseases. Cytokine Growth Factor Rev. 2004; 15(4):255-73. PMID: 15207816
38. Schuppan D, Kim YO. Evolving therapies for liver fibrosis. J Clin Invest. 2013; 123(5):1887-901. doi: 10.1172/JCI66028 PMID: 23635787
39. Friedman SL, Sheppard D, Duffield JS, Violette S. Therapy for fibrotic diseases: nearing the starting line. Sci Transl Med. 2013; 5(167):167sr1. doi: 10.1126/scitranslmed.3004700 PMID: 23303606
40. Poli G. Pathogenesis of liver fibrosis: role of oxidative stress. Mol Aspects Med. 2000; 21(3):49-98. PMID: 10978499
41. Kmiec Z. Cooperation of liver cells in health and disease. Adv Anat Embryol Cell Biol. 2001; 161:III-XIII, 1-151. PMID: 11729749
42. Svegliati Baroni G, D'Ambrosio L, Ferretti G, Casini A, Di Sario A, Salzano R, et al. Fibrogenic effect of oxidative stress on rat hepatic stellate cells. Hepatology. 1998; 27(3):720-6. PMID: 9500700
43. Novo E, Busletta C, Bonzo LV, Povero D, Paternostro C, Mareschi K, et al. Intracellular reactive oxygen species are required for directional migration of resident and bone marrow-derived hepatic pro-fibrogenic cells. J Hepatol. 2011; 54(5):964-74. doi: 10.1016/j.jhep.2010.09.022 PMID: 21145826
44. Stites T, Storms D, Bauerly K, Mah J, Harris C, Fascetti A, et al. Pyrroloquinoline quinone modulates mitochondrial quantity and function in mice. J Nutr. 2006; 136(2):390-6. PMID: 16424117
45. Ledda-Columbano GM, Coni P, Curto M, Giacomini L, Faa G, Oliverio S, et al. Induction of two different modes of cell death, apoptosis and necrosis, in rat liver after a single dose of thioacetamide. Am J Pathol. 1991; 139(5):1099-109. PMID: 1683163
46. de David C, Rodrigues G, Bona S, Meurer L, Gonzalez-Gallego J, Tunon MJ, et al. Role of quercetin in preventing thioacetamide-induced liver injury in rats. Toxicol Pathol. 2011; 39(6):949-57. doi: 10.1177/0192623311418680 PMID: 21885874
47. Uskokovic-Markovic S, Milenkovic M, Topic A, Kotur-Stevuljevic J, Stefanovic A, Antic-Stankovic J. Protective effects of tungstophosphoric acid and sodium tungstate on chemically induced liver necrosis in wistar rats. J Pharm Pharm Sci. 2007; 10(3):340-9. PMID: 17727797
48. Rhyu DY, Yang Y, Ha H, Lee GT, Song JS, Uh ST, et al. Role of reactive oxygen species in TGF-beta1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells. J Am Soc Nephrol. 2005; 16(3):667-75. PMID: 15677311
49. Svegliati S, Cancello R, Sambo P, Luchetti M, Paroncini P, Orlandini G, et al. Platelet-derived growth factor and reactive oxygen species (ROS) regulate Ras protein levels in primary human fibroblasts via ERK1/2. Amplification of ROS and Ras in systemic sclerosis fibroblasts. J Biol Chem. 2005; 280 (43):36474-82. PMID: 16081426
50. Harris CB, Chowanadisai W, Mishchuk DO, Satre MA, Slupsky CM, Rucker RB. Dietary pyrroloquinoline quinone (PQQ) alters indicators of inflammation and mitochondrial-related metabolism in human subjects. J Nutr Biochem. 2013; 24(12):2076-84. doi: 10.1016/j.jnutbio.2013.07.008 PMID: 24231099